Home›Research›Compare›Retatrutide vs Sermorelin
Peptide ComparisonRetatrutide vs Sermorelin
Retatrutide
LY3437943
Half-life: ~6 days
98 providers listed
Sermorelin
GHRH 1-29
Half-life: 10–20 minutes
445 providers listed
Retatrutide and Sermorelin target different goals — Retatrutide for profound weight loss, Sermorelin for pulsatile GH release via direct GHRH receptor agonism at the pituitary. They're compared here for reference, not as direct substitutes.
Retatrutide
Evidence
Half-life
~6 days
Sermorelin
Evidence
Half-life
10–20 minutes
Retatrutide and Sermorelin target different goals — Retatrutide for Metabolic, Sermorelin for GH / IGF Axis. They're compared here for reference; there isn't a single “better” choice between them.
Retatrutide
Sermorelin
Retatrutide
Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial
Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review.
Beyond weight loss: multisystem benefits of obesity medications.
Retatrutide: Triple acting jab for type 2 diabetes lowers blood sugar and boosts weight loss, trial reports.
+9 more
Sermorelin
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients…
The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostat…
About Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist; targets three pathways for synergistic fat reduction
About Sermorelin
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on pituitary somatotrophs, stimulating pulsatile GH secretion in a physiological pattern that preserves the natural hypothalamic-pituitary feedback axis — contrasting with direct GH administration. Downstream IGF-1 elevation mediates many of its body composition, tissue-repair, and sleep quality effects.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Retatrutide
Class-based (investigational)
Sermorelin
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Sermorelin clinical protocols measure IGF-1 as the primary marker of GH axis response. Fasting glucose and insulin are standard baseline assessments given GH's effect on insulin sensitivity.
Sermorelin
Ipamorelin
Research suggests Sermorelin and Ipamorelin may produce complementary growth hormone release effects when combined. Sermorelin acts as a GHRH analogue via pituitary receptors, while Ipamorelin acts via ghrelin receptors — dual-pathway stimulation studied in GH optimization research.
Retatrutide
Sermorelin
Where to source these peptides
Retatrutide
98 listed
Browse directory →
Providers offeringSermorelin
445 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
Related Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Retatrutide vs Sermorelin — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/retatrutide/sermorelin